CHURG-STRAUSS SYNDROME
Clinical trials for CHURG-STRAUSS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CHURG-STRAUSS SYNDROME trials appear
Sign up with your email to follow new studies for CHURG-STRAUSS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood vessel disease: drug aims to cut steroids
Disease control Recruiting nowThis study tests a new medicine called NS-229 for people with a rare disease called eosinophilic granulomatosis with polyangiitis (EGPA), which causes inflammation in blood vessels. The goal is to see if NS-229 can help patients achieve remission (no symptoms) while taking a lowe…
Matched conditions: CHURG-STRAUSS SYNDROME
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
Tissue bank aims to unlock secrets of rare blood vessel diseases
Knowledge-focused Recruiting nowThis study collects tissue samples from 1,000 people with various forms of vasculitis (blood vessel inflammation). Researchers will analyze the samples along with medical data to find genes linked to the disease and spark new ideas for diagnosis and treatment. Participants must a…
Matched conditions: CHURG-STRAUSS SYNDROME
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 17, 2026 03:56 UTC
-
Scientists hunt for clues to rare immune disease in 700-Patient study
Knowledge-focused Recruiting nowThis study follows 700 people with eosinophilic granulomatosis with polyangiitis (EGPA), a rare immune disorder causing asthma, high eosinophil levels, and blood vessel inflammation. Researchers aim to discover biological markers that can measure how active the disease is and how…
Matched conditions: CHURG-STRAUSS SYNDROME
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 17, 2026 03:56 UTC